|
VKORC1L1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.720180E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.074000E-01 |
| Normal-vs-Stage2 |
3.120200E-01 |
| Normal-vs-Stage3 |
1.400160E-01 |
| Normal-vs-Stage4 |
3.206800E-01 |
| Stage1-vs-Stage2 |
7.229800E-01 |
| Stage1-vs-Stage3 |
3.539600E-01 |
| Stage1-vs-Stage4 |
6.383200E-01 |
| Stage2-vs-Stage3 |
6.825000E-01 |
| Stage2-vs-Stage4 |
8.273400E-01 |
| Stage3-vs-Stage4 |
8.962000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.038100E-02 |
| Normal-vs-AfricanAmerican |
3.033600E-01 |
| Normal-vs-Asian |
9.437200E-01 |
| Caucasian-vs-AfricanAmerican |
5.710800E-01 |
| Caucasian-vs-Asian |
6.777800E-01 |
| AfricanAmerican-vs-Asian |
7.662200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.680800E-01 |
| Normal-vs-Female |
8.811900E-04 |
| Male-vs-Female |
5.642000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.611200E-01 |
| Normal-vs-Extreme_Weight |
4.178400E-01 |
| Normal-vs-Obese |
4.401800E-02 |
| Normal-vs-Extreme_Obese |
4.924600E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.985000E-01 |
| Normal_Weight-vs-Obese |
2.931600E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.546800E-01 |
| Extreme_Weight-vs-Obese |
3.377400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.811000E-01 |
| Obese-vs-Extreme_Obese |
1.274220E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.761700E-02 |
| Normal-vs-Age(41-60Yrs) |
2.396000E-03 |
| Normal-vs-Age(61-80Yrs) |
9.732000E-01 |
| Normal-vs-Age(81-100Yrs) |
8.317800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.593800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.832400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.594200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.579400E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.779200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.823600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.177700E-03 |
| Normal-VS-Type2 PRCC |
1.766430E-01 |
| Normal-VS-KIRP CIMP |
5.002300E-03 |
| Normal-VS-Unclassified PRCC |
6.409600E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.544210E-03 |
| Type1 PRCC-VS-KIRP CIMP |
7.639800E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
5.316000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.86669999966161E-07 |
| Type2 PRCC-VS-Unclassified PRCC |
1.428200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.994300E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.156400E-01 |
| Normal-vs-N1 |
2.674100E-02 |
| Normal-vs-N2 |
1.550590E-01 |
| N0-vs-N1 |
7.604700E-03 |
| N0-vs-N2 |
1.124190E-02 |
| N1-vs-N2 |
5.606200E-01 |
|
|
